Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gail Rock

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Transfusion Medicine Reviews|April 3, 2007
Guidelines on the use of intravenous immune globulin for hematologic conditionsDavid Anderson, Kaiser Ali, Victor Blanchette, et al.
Journal of Thrombosis and Haemostasis : JTH|September 11, 2020
ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpuraX Long Zheng, Sara K Vesely, Spero R Cataland, et al.
Journal of Thrombosis and Haemostasis : JTH|September 11, 2020
ISTH guidelines for treatment of thrombotic thrombocytopenic purpuraX Long Zheng, Sara K Vesely, Spero R Cataland, et al.
Journal of Thrombosis and Haemostasis : JTH|September 11, 2020
Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpuraX Long Zheng, Sara K Vesely, Spero R Cataland, et al.
American Journal of Hematology|February 28, 2012
Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpuraSpero R Cataland, Flora Peyvandi, Pier M Mannucci, et al.
British Journal of Haematology|March 28, 2013
Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR)Charles L Bennett, Sony Jacob, Brianne L Dunn, et al.
Seminars in Thrombosis and Hemostasis|November 1, 2012
Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)Sony Jacob, Brianne L Dunn, Zaina P Qureshi, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Transfusion Medicine Reviews|April 3, 2007
Guidelines on the use of intravenous immune globulin for hematologic conditionsDavid Anderson, Kaiser Ali, Victor Blanchette, et al.
Journal of Thrombosis and Haemostasis : JTH|September 11, 2020
ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpuraX Long Zheng, Sara K Vesely, Spero R Cataland, et al.
Journal of Thrombosis and Haemostasis : JTH|September 11, 2020
ISTH guidelines for treatment of thrombotic thrombocytopenic purpuraX Long Zheng, Sara K Vesely, Spero R Cataland, et al.
Journal of Thrombosis and Haemostasis : JTH|September 11, 2020
Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpuraX Long Zheng, Sara K Vesely, Spero R Cataland, et al.
American Journal of Hematology|February 28, 2012
Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpuraSpero R Cataland, Flora Peyvandi, Pier M Mannucci, et al.
British Journal of Haematology|March 28, 2013
Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR)Charles L Bennett, Sony Jacob, Brianne L Dunn, et al.
Seminars in Thrombosis and Hemostasis|November 1, 2012
Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)Sony Jacob, Brianne L Dunn, Zaina P Qureshi, et al.
Pageof 9